Product Images Losartan Potassium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Losartan Potassium NDC 76519-1033 by H.j. Harkins Company, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

label - 76519 1033 PPAC LABEL

label - 76519 1033 PPAC LABEL

This is a label text of Losartan Potassium 100mg Tab, a prescription medicine which should only be taken as directed by a physician. It is prohibited by the Federal Law to transfer the drug to anyone other than the person it is prescribed to. It should be kept out of reach of children and stored at temperatures between 68-77°F. The medicine compares with another called Gozaat. The label includes the manufacturer's name, expiration date, lot number, and account number. The manufacturer's National Drug Code is also present. The label is from Camber Pharma and it also includes the name of a company called H.J. Harkin Co. located in Grover Beach, CA 03433.*

76519 1148 PPAC LABEL

76519 1148 PPAC LABEL

This is a medication label for Losartan Potassium 25mg tablets. The label contains important cautionary information, which includes not transferring the medication to anyone other than the person for whom it is prescribed and only dispensing it with a valid prescription, unless it is available over the counter. The label also specifies that the medication should be kept out of reach of children and stored at temperatures between 66-77°F. The medication is manufactured by a company called Mig. Gamber Pharma and packaged by Ropack: H.J. Harkin Co., Inc. The label also contains information regarding the medication's expiration date, lot number, and manufacturing NDC (national drug code). The medication should be used as directed by a physician.*

Figure1 - Figure1

Figure1 - Figure1

Figure2 - Figure2

Figure2 - Figure2

The given text provides information about the adjusted risk reduction of a study in percentage and its statistical significance (p-value). It also includes a graph showing the percentage of patients with first-line or fatal stroke over a period of 66 months. No further information is available.*

Figure3 - Figure3

Figure3 - Figure3

Figure4 - Figure4

Figure4 - Figure4

This text is providing information about the percentage of patents with an event related to risk reduction, which is 18.1% (0022). It also mentions the time period, which is expressed in months.*

image - image

image - image

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.